Physician profile
Judith B Coran
NPI 1518951136
$3,024.52
in general payments reported to CMS, 2019-2025
19 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2020: $111 · 2021: $131 · 2022: $113 · 2023: $259 · 2024: $526 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,276.79 | 2019 | |
| Abbvie INC. | $407.54 | 2019-2025 | Lumigan |
| Oyster Point Pharma, INC. | $212.10 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Alcon Vision LLC | $194.26 | 2023-2025 | Clareon, Hydrus Microstent, Tryptyr |
| Novartis Pharmaceuticals Corporation | $158.26 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $141.55 | 2024-2025 | Xdemvy |
| Allergan, INC. | $125.84 | 2019-2022 | |
| Amgen INC. | $75.10 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $73.11 | 2023-2024 | Iyuzeh |
| Bausch & Lomb Americas INC. | $69.00 | 2024-2025 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $55.67 | 2019-2024 | |
| Harrow Eye, LLC | $53.24 | 2024 | Vevye |
| Biotissue Holdings INC. | $51.08 | 2019-2020 | |
| Dompe US, INC. | $38.97 | 2019-2025 | Oxervate |
| Astellas Pharma US INC | $21.13 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $19.27 | 2023 | Tepezza |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Shire North American Group INC | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Coran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.